artificial intelligence (ai) in drug discovery market

Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity

  • Published Date: 2020-10-15
  • Report ID: 2293
  • Pages: 178
  • Format: prudent report format

Global artificial intelligence (AI) in drug discovery market will reach $2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.
Highlighted with 86 tables and 86 figures, this 178-page report Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.
Based on offering, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Software
Service
Based on technology, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Technologies
Based on drug type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Large-molecule Drugs
Small-molecular Drugs
Based on therapeutic area, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Other Therapeutic Areas
Based on application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Information & Data Analysis
Drug Design
Drug Evaluation
Clinical Trials
Other Applications
Based on end user, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
Geographically, the following regions together with the listed national/local markets are fully investigated:
APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
North America (U.S., Canada, and Mexico)
South America (Brazil, Chile, Argentina, Rest of South America)
RoW (Saudi Arabia, UAE, Egypt)
For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porters Fiver Forces Analysis 35
3 Segmentation of Global Market by Offering 39
3.1 Market Overview by Offering 39
3.2 Software 41
3.3 Service 42
4 Segmentation of Global Market by Technology 43
4.1 Market Overview by Technology 43
4.2 Deep Learning 45
4.3 Supervised Learning 46
4.4 Reinforcement Learning 47
4.5 Unsupervised Learning 48
4.6 Other Technologies 49
5 Segmentation of Global Market by Drug Type 50
5.1 Market Overview by Drug Type 50
5.2 Large-molecule Drugs 52
5.3 Small-molecular Drugs 53
6 Segmentation of Global Market by Therapeutic Area 54
6.1 Market Overview by Therapeutic Area 54
6.2 Oncology 57
6.3 Neurodegenerative Diseases 58
6.4 Cardiovascular Disease 59
6.5 Metabolic Diseases 60
6.6 Other Therapeutic Areas 61
7 Segmentation of Global Market by Application 62
7.1 Market Overview by Application 62
7.2 Information & Data Analysis 64
7.3 Drug Design 65
7.4 Drug Evaluation 66
7.5 Clinical Trials 67
7.6 Other Applications 68
8 Segmentation of Global Market by End User 69
8.1 Market Overview by End User 69
8.2 Pharmaceutical & Biotechnology Companies 71
8.3 Academic & Research Institutes 72
8.4 Contract Research Organizations 73
9 Segmentation of Global Market by Region 74
9.1 Geographic Market Overview 2019-2026 74
9.2 North America Market 2019-2026 by Country 78
9.2.1 Overview of North America Market 78
9.2.2 U.S. 82
9.2.3 Canada 86
9.2.4 Mexico 88
9.3 European Market 2019-2026 by Country 90
9.3.1 Overview of European Market 90
9.3.2 UK 94
9.3.3 France 96
9.3.4 Germany 98
9.3.5 Spain 100
9.3.6 Italy 102
9.3.7 Russia 104
9.3.8 Rest of European Market 106
9.4 Asia-Pacific Market 2019-2026 by Country 108
9.4.1 Overview of Asia-Pacific Market 108
9.4.2 China 111
9.4.3 Japan 113
9.4.4 India 116
9.4.5 Australia 118
9.4.6 South Korea 120
9.4.7 Rest of APAC Region 122
9.5 South America Market 2019-2026 by Country 124
9.5.1 Argentina 127
9.5.2 Brazil 129
9.5.3 Chile 131
9.5.4 Rest of South America Market 133
9.6 Rest of World Market 2019-2026 by Country 134
9.6.1 UAE 137
9.6.2 Saudi Arabia 139
9.6.3 Egypt 141
9.6.4 Other National Markets 143
10 Competitive Landscape 144
10.1 Overview of Key Vendors 144
10.2 New Product Launch, Partnership, Investment, and M&A 149
10.3 Company Profiles 150
Atomwise, Inc. 150
BenevolentAI 152
Berg LLC 153
Bioage 154
BIOAGE 155
Cloud Pharmaceuticals, Inc. 156
Cyclica 157
Deep Genomics 158
Envisagenics 159
Exscientia 160
Google 161
IBM Corporation 162
Insilico Medicine 163
Microsoft Corporation 164
Numedii, Inc. 165
Numerate 166
NVIDIA Corporation 167
Owkin, Inc. 168
Twoxar, Incorporated 169
Verge Genomics 170
Xtalpi, Inc. 171
11 Investing in Global Market: Risk Assessment and Management 172
11.1 Risk Evaluation of Global Market 172
11.2 Critical Success Factors (CSFs) 175
Related Reports and Products 178
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.